Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q2- Text added to 2020 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
AASLD, Afimmune, AHFIRM, Biopharma, BMS, channel, Chinese, CytoDyn, ENYO, expressly, FD, Hanmi, HighTide, inactive, Isotechnika, Kowa, LifeMax, lift, lifted, Lipidio, Lipocine, MediciNova, methylprednisolone, Mitsubishi, national, NorthSea, OP, PharmaKing, posted, poster, Poxel, Promethera, proxy, reimpose, routine, slightly, SOC, sterile, Tanabe, textual, Thera, TLMdX, virtually, website, workforce
Valuein 2020 Q2 filing- Value in 2020 Q3 filing
Original filings
Filing view